BioStock: WntResearch advances recruitment and initiates research collaboration

As we approach the summer holiday, there is growing interest in this winter’s upcoming results from WntResearch's phase II study NeoFox. The company recently announced that it has achieved the recruitment target of a total of 120 patients for the interim analysis. At the same time, WnResearch has initiated a research collaboration to further supplement the Brazilian preclinical findings regarding Foxy-5's potential as a treatment for acute myeloid leukemia. BioStock contacted the company's newly appointed CEO Pernilla Sandwall to find out more.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/07/wntresearch-reaches-recruitment-goal-and-initiates-research-collaboration/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se